November 30, 2020

Biologics Safety Testing Market Expected to Reach at a US$ 4.8 Bn by 2027

As per the research held by Acumen Research and Consulting, “the global Biologics Safety Testing market anticipated to exceed US$ 4.8 Bn by 2027, along with the projected CAGR of 11.7% from 2020 to 2027”.

The global Biologics Safety Testing market research report encompasses qualitative and quantitative data derived from the analysis by experts and research analysts in the respective industry verticals from valid sources with the help of primary and secondary research tools.

Get Sample PDF @ https://www.acumenresearchandconsulting.com/request-sample/1656

The major market factors which are driving, hindering, challenging, or providing opportunities are specifically covered to better understand the market position, Recent market trends and governmental regulation & standards are additionally incorporated.

The research report has majorly profiled market information, DROs, segmentation, regional instance, and competitive landscape. The aforementioned entities further encompass prominent sections according to the need of the respective market. Moreover, regional segmentation includes North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and their respective major countries. The dipper information is profiled in terms of regions for getting recent and expected trends and opportunities in the regional market.

Furthermore, in terms of prominent players, the research report comprises a number of major players that are operating in the global competitive environment and offering advance and value-added products to the consumers. A detailed analysis is executed on these players in terms of the business snapshot, product offerings, financial overview, strategic development, player positioning, and R&D investment. This information is essential for the competitors and those who are planning to enter the market.

In a nutshell, the research report is a completely designed solution for those who are seeking information and available opportunities to take decisions of expansion in the desired market. As well as, the research report is also a value-added solution of the research students to get more specific information associated with the market.

Market participants

Charles River Laboratories, SGS SA, Lonza Group LTD, Merck KGaA, and WuXi Apptec, Thermo Fisher Scientific Inc., Sartorius AG, Cytovance Biologics, Inc., Pace Analytical Services Inc., Eurofins Scientific Se, Avance Biosciences Inc., Source Bioscience, and Toxikon Corporation among others.

Market segmentation

Market By Product Type

  • Kits & Reagents
  • Instruments

Market By Application

  • Blood and Blood-related Products Testing
  • Vaccine and Therapeutics Development
  • Cellular and Gene Therapy
  • Tissue and Tissue-related Products Testing
  • Stem Cell Research

Market By Test Type

  • Endotoxin Tests
  • Sterility Tests
  • Cell Line Authentication and Characterization Tests
  • Residual Host Contamination Detection Tests
  • Adventitious Agent Detection Tests
  • Bioburden tests
  • Other Tests

Market By Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table of content

CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
1.1.1. Definition of Biologics Safety Testing
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Biologics Safety Testing Market By Application
1.2.2.1. Global Biologics Safety Testing Market Revenue and Growth Rate Comparison By Application (2015-2026)
1.2.2.2. Global Biologics Safety Testing Market Revenue Share By Application in 2017
1.2.2.3. Vaccine and Therapeutics Development
1.2.2.4. Blood and Blood-related Products Testing
1.2.2.5. Cellular and Gene Therapy
1.2.2.6. Tissue and Tissue-related Products Testing
1.2.2.7. Stem Cell Research
1.2.3. Biologics Safety Testing Market By Product Type
1.2.3.1. Global Biologics Safety Testing Market Revenue and Growth Rate Comparison By Product Type (2015-2026)
1.2.3.2. Global Biologics Safety Testing Market Revenue Share By Product Type in 2017
1.2.3.3. Kits & Reagents
1.2.3.4. Instruments
1.2.4. Biologics Safety Testing Market By Test Type
1.2.4.1. Global Biologics Safety Testing Market Revenue and Growth Rate Comparison By Test Type (2015-2026)
1.2.4.2. Global Biologics Safety Testing Market Revenue Share By Test Type in 2017
1.2.4.3. Sterility Tests
1.2.4.4. Endotoxin Tests
1.2.4.5. Cell Line Authentication and Characterization Tests
1.2.4.6. Residual Host Contamination Detection Tests
1.2.4.7. Adventitious Agent Detection Tests
1.2.4.8. Bioburden tests
1.2.4.9. Others
1.2.5. Biologics Safety Testing Market By Geography
1.2.5.1. Global Biologics Safety Testing Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.5.2. North America Biologics Safety Testing Market Revenue and Growth Rate (2015-2026)
1.2.5.3. Europe Biologics Safety Testing Market Revenue and Growth Rate (2015-2026)
1.2.5.4. Asia-Pacific Biologics Safety Testing Market Revenue and Growth Rate (2015-2026)
1.2.5.5. Latin America Biologics Safety Testing Market Revenue and Growth Rate (2015-2026)
1.2.5.6. Middle East and Africa (MEA) Biologics Safety Testing Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Commercial Production Date of Global Biologics Safety Testing Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Biologics Safety Testing Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global Biologics Safety Testing Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Biologics Safety Testing Major Manufacturers in 2017

CHAPTER 4. BIOLOGICS SAFETY TESTING MARKET BY APPLICATION
4.1. Global Biologics Safety Testing Revenue By Application
4.2. Vaccine and Therapeutics Development
4.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.3. Blood and Blood-related Products Testing
4.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.4. Cellular and Gene Therapy
4.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.5. Tissue and Tissue-related Products Testing
4.5.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.6. Stem Cell Research
4.6.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.6.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)

CHAPTER 5. BIOLOGICS SAFETY TESTING MARKET BY PRODUCT TYPE
5.1. Global Biologics Safety Testing Revenue By Product Type
5.2. Kits & Reagents
5.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.3. Instruments
5.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)

CHAPTER 6. BIOLOGICS SAFETY TESTING MARKET BY TEST TYPE
6.1. Global Biologics Safety Testing Revenue By Test Type
6.2. Sterility Tests
6.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
6.3. Endotoxin Tests
6.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
6.4. Cell Line Authentication and Characterization Tests
6.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
6.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
6.5. Residual Host Contamination Detection Tests
6.5.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
6.5.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
6.6. Adventitious Agent Detection Tests
6.6.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
6.6.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
6.7. Bioburden tests
6.7.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
6.7.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
6.8. Others
6.8.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
6.8.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)

CHAPTER 7. NORTH AMERICA BIOLOGICS SAFETY TESTING MARKET BY COUNTRY
7.1. North America Biologics Safety Testing Market Revenue and Growth Rate, 2015 – 2026 ($Million)
7.2. North America Biologics Safety Testing Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. U.S.
7.3.1. U.S. Biologics Safety Testing Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
7.3.2. Market Revenue and Forecast By Product Type, 2015 – 2026 ($Million)
7.3.3. Market Revenue and Forecast By Test Type, 2015 – 2026 ($Million)
7.4. Canada
7.4.1. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
7.4.2. Market Revenue and Forecast By Product Type, 2015 – 2026 ($Million)
7.4.3. Market Revenue and Forecast By Test Type, 2015 – 2026 ($Million)

CHAPTER 8. EUROPE BIOLOGICS SAFETY TESTING MARKET BY COUNTRY
8.1. Europe Biologics Safety Testing Market Revenue and Growth Rate, 2015 – 2026 ($Million)
8.2. Europe Biologics Safety Testing Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. UK
8.3.1. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
8.3.2. Market Revenue and Forecast By Product Type, 2015 – 2026 ($Million)
8.3.3. Market Revenue and Forecast By Test Type, 2015 – 2026 ($Million)
8.4. Germany
8.4.1. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
8.4.2. Market Revenue and Forecast By Product Type, 2015 – 2026 ($Million)
8.4.3. Market Revenue and Forecast By Test Type, 2015 – 2026 ($Million)
8.5. France
8.5.1. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
8.5.2. Market Revenue and Forecast By Product Type, 2015 – 2026 ($Million)
8.5.3. Market Revenue and Forecast By Test Type, 2015 – 2026 ($Million)
8.6. Spain
8.6.1. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
8.6.2. Market Revenue and Forecast By Product Type, 2015 – 2026 ($Million)
8.6.3. Market Revenue and Forecast By Test Type, 2015 – 2026 ($Million)
8.7. Rest of Europe
8.7.1. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
8.7.2. Market Revenue and Forecast By Product Type, 2015 – 2026 ($Million)
8.7.3. Market Revenue and Forecast By Test Type, 2015 – 2026 ($Million)

CHAPTER 9. ASIA-PACIFIC BIOLOGICS SAFETY TESTING MARKET BY COUNTRY
9.1. Asia-Pacific Biologics Safety Testing Market Revenue and Growth Rate, 2015 – 2026 ($Million)
9.2. Asia-Pacific Biologics Safety Testing Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. China
9.3.1. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
9.3.2. Market Revenue and Forecast By Product Type, 2015 – 2026 ($Million)
9.3.3. Market Revenue and Forecast By Test Type, 2015 – 2026 ($Million)
9.4. Japan
9.4.1. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
9.4.2. Market Revenue and Forecast By Product Type, 2015 – 2026 ($Million)
9.4.3. Market Revenue and Forecast By Test Type, 2015 – 2026 ($Million)
9.5. India
9.5.1. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
9.5.2. Market Revenue and Forecast By Product Type, 2015 – 2026 ($Million)
9.5.3. Market Revenue and Forecast By Test Type, 2015 – 2026 ($Million)
9.6. Australia
9.6.1. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
9.6.2. Market Revenue and Forecast By Product Type, 2015 – 2026 ($Million)
9.6.3. Market Revenue and Forecast By Test Type, 2015 – 2026 ($Million)
9.7. South Korea
9.7.1. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
9.7.2. Market Revenue and Forecast By Product Type, 2015 – 2026 ($Million)
9.7.3. Market Revenue and Forecast By Test Type, 2015 – 2026 ($Million)
9.8. Rest of Asia-Pacific
9.8.1. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
9.8.2. Market Revenue and Forecast By Product Type, 2015 – 2026 ($Million)
9.8.3. Market Revenue and Forecast By Test Type, 2015 – 2026 ($Million)

CHAPTER 10. LATIN AMERICA BIOLOGICS SAFETY TESTING MARKET BY COUNTRY
10.1. Latin America Biologics Safety Testing Market Revenue and Growth Rate, 2015 – 2026 ($Million)
10.2. Latin America Biologics Safety Testing Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Brazil
10.3.1. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
10.3.2. Market Revenue and Forecast By Product Type, 2015 – 2026 ($Million)
10.3.3. Market Revenue and Forecast By Test Type, 2015 – 2026 ($Million)
10.4. Mexico
10.4.1. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
10.4.2. Market Revenue and Forecast By Product Type, 2015 – 2026 ($Million)
10.4.3. Market Revenue and Forecast By Test Type, 2015 – 2026 ($Million)
10.5. Rest of Latin America
10.5.1. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
10.5.2. Market Revenue and Forecast By Product Type, 2015 – 2026 ($Million)
10.5.3. Market Revenue and Forecast By Test Type, 2015 – 2026 ($Million)

CHAPTER 11. MIDDLE EAST & AFRICA BIOLOGICS SAFETY TESTING MARKET BY COUNTRY
11.1. Middle East & Africa Biologics Safety Testing Market Revenue and Growth Rate, 2015 – 2026 ($Million)
11.2. Middle East & Africa Biologics Safety Testing Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. GCC
11.3.1. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
11.3.2. Market Revenue and Forecast By Product Type, 2015 – 2026 ($Million)
11.3.3. Market Revenue and Forecast By Test Type, 2015 – 2026 ($Million)
11.4. Saudi Africa
11.4.1. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
11.4.2. Market Revenue and Forecast By Product Type, 2015 – 2026 ($Million)
11.4.3. Market Revenue and Forecast By Test Type, 2015 – 2026 ($Million)
11.5. Rest of Middle East & Africa
11.5.1. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
11.5.2. Market Revenue and Forecast By Product Type, 2015 – 2026 ($Million)
11.5.3. Market Revenue and Forecast By Test Type, 2015 – 2026 ($Million)

CHAPTER 12. COMPANY PROFILE
12.1. Charles River Laboratories
12.1.1. Company Snapshot
12.1.2. Overview
12.1.3. Financial Overview
12.1.4. Product Portfolio
12.1.5. Key Developments
12.1.6. Strategies
12.2. SGS SA
12.2.1. Company Snapshot
12.2.2. Overview
12.2.3. Financial Overview
12.2.4. Product Portfolio
12.2.5. Key Developments
12.2.6. Strategies
12.3. Lonza Group LTD
12.3.1. Company Snapshot
12.3.2. Overview
12.3.3. Financial Overview
12.3.4. Product Portfolio
12.3.5. Key Developments
12.3.6. Strategies
12.4. Merck KGaA
12.4.1. Company Snapshot
12.4.2. Overview
12.4.3. Financial Overview
12.4.4. Product Portfolio
12.4.5. Key Developments
12.4.6. Strategies
12.5. WuXi Apptec
12.5.1. Company Snapshot
12.5.2. Overview
12.5.3. Financial Overview
12.5.4. Product Portfolio
12.5.5. Key Developments
12.5.6. Strategies
12.6. Thermo Fisher Scientific Inc.
12.6.1. Company Snapshot
12.6.2. Overview
12.6.3. Financial Overview
12.6.4. Product Portfolio
12.6.5. Key Developments
12.6.6. Strategies
12.7. Sartorius AG
12.7.1. Company Snapshot
12.7.2. Overview
12.7.3. Financial Overview
12.7.4. Product Portfolio
12.7.5. Key Developments
12.7.6. Strategies
12.8. Cytovance Biologics, Inc.
12.8.1. Company Snapshot
12.8.2. Overview
12.8.3. Financial Overview
12.8.4. Product Portfolio
12.8.5. Key Developments
12.8.6. Strategies
12.9. Pace Analytical Services Inc.
12.9.1. Company Snapshot
12.9.2. Overview
12.9.3. Financial Overview
12.9.4. Product Portfolio
12.9.5. Key Developments
12.9.6. Strategies
12.10. Eurofins Scientific Se
12.10.1. Company Snapshot
12.10.2. Overview
12.10.3. Financial Overview
12.10.4. Product Portfolio
12.10.5. Key Developments
12.10.6. Strategies
12.11. Avance Biosciences Inc.
12.11.1. Company Snapshot
12.11.2. Overview
12.11.3. Financial Overview
12.11.4. Product Portfolio
12.11.5. Key Developments
12.11.6. Strategies
12.12. Source Bioscience
12.12.1. Company Snapshot
12.12.2. Overview
12.12.3. Financial Overview
12.12.4. Product Portfolio
12.12.5. Key Developments
12.12.6. Strategies
12.13. Toxikon Corporation
12.13.1. Company Snapshot
12.13.2. Overview
12.13.3. Financial Overview
12.13.4. Product Portfolio
12.13.5. Key Developments
12.13.6. Strategies
12.14. Others
12.14.1. Company Snapshot
12.14.2. Overview
12.14.3. Financial Overview
12.14.4. Product Portfolio
12.14.5. Key Developments
12.14.6. Strategies

CHAPTER 13. RESEARCH APPROACH
13.1. Research Methodology
13.1.1. Initial Data Search
13.1.2. Secondary Research
13.1.3. Primary Research
13.2. Assumptions and Scope

Buy this premium report @ https://www.acumenresearchandconsulting.com/buy-now/0/1656

Contact us:

Sheetal k

Email: sales@acumenresearchandconsulting.com

Phone: +14079154157 | +14089009135

Website: https://www.acumenresearchandconsulting.com

THOMAS ROBBINS

is a freelancer, a graduate of the University of Pennsylvania with a BA in English, he studied accounting at the Wharton School of Business, and currently lives in Staten Island has been covering business and technology for a variety of publications since 1989. He worked for Red Herring, Beyond Computing & Accounting Technolgy. He covers accounting, taxes, finance, government news & technology for the site Mail me

thomasrobbins@globepredict.com

View all posts by THOMAS ROBBINS →

Leave a Reply

Your email address will not be published. Required fields are marked *